| lncRNA ZEB2‐AS1: A promising biomarker in human cancers Z Mahboobeh, M Pegah, S Fatemeh, K Elham, A Hanieh, R Milad, ... Iubmb Life 72 (9), 1891-1899, 2020 | 23 | 2020 |
| Construction of a lncRNA–miRNA–mRNA network to determine the key regulators of the Th1/Th2 imbalance in multiple sclerosis H Azari, E Karimi, M Shekari, A Tahmasebi, AR Nikpoor, AA Negahi, ... Epigenomics 13 (22), 1797-1815, 2021 | 18 | 2021 |
| LncRNA‐miRNA network analysis across the Th17 cell line reveals biomarker potency of lncRNA NEAT1 and KCNQ1OT1 in multiple sclerosis E Karimi, H Azari, A Tahmasebi, AR Nikpoor, AA Negahi, N Sanadgol, ... Journal of Cellular and Molecular Medicine 26 (8), 2351-2362, 2022 | 16 | 2022 |
| Machine learning algorithms reveal potential miRNAs biomarkers in gastric cancer H Azari, E Nazari, R Mohit, A Asadnia, M Maftooh, M Nassiri, ... Scientific Reports 13 (1), 6147, 2023 | 15 | 2023 |
| The expanding role of CDR1‐AS in the regulation and development of cancer and human diseases H Azari, P Mousavi, E Karimi, F Sadri, M Zarei, M Rafat, M Shekari Journal of Cellular Physiology 236 (2), 771-790, 2021 | 12 | 2021 |
| Interplay between SARS‐CoV‐2‐derived miRNAs, immune system, vitamin D pathway and respiratory system E Karimi, H Azari, M Yari, A Tahmasebi, M Hassani Azad, P Mousavi Journal of cellular and molecular medicine 25 (16), 7825-7839, 2021 | 9 | 2021 |
| Molecular mechanisms of miR-214 involved in Cancer and Drug Resistance E Karimi, A Dehghani, H Azari, M Zarei, M Shekari, P Mousavi Current Molecular Medicine 23 (7), 589-605, 2023 | 4 | 2023 |
| Personalized medicine and new therapeutic approach in the treatment of pancreatic cancer H Azari, E Nazari, H Jamialahmadi, G Khalili-Tanha, M Maftooh, ... Recent Advances in Nanocarriers for Pancreatic Cancer Therapy, 317-343, 2024 | 1 | 2024 |
| The Prognostic Value of ASPHD1 and ZBTB12 in Colorectal Cancer: A Machine Learning-Based Integrated Bioinformatics Approach A Asadnia, E Nazari, L Goshayeshi, N Zafari, M Moetamani-Ahmadi, ... Cancers 15 (17), 4300, 2023 | 1 | 2023 |
| G-Protein Signaling Modulator 2 as a Potential Biomarker in Colorectal Cancer: Integrative Analysis Using Genetic Profiling and Pan-Cancer Studies DJ Kadhim, H Azari, SK Sokhangouy, SM Hassanian, HI Alshekarchi, ... Genes 15 (4), 474, 2024 | | 2024 |
| The Prognostic Value of ASPHD1 and ZBTB12 in Colorectal Cancer: A Machine Learning-Based Integrated Bioinformatics Approach. Cancers 2023, 15, 4300 A Asadnia, E Nazari, L Goshayeshi, N Zafari, M Moetamani-Ahmadi, ... | | 2023 |
Elham KarimiDepartment of Medical Genetics, School of Medicine, Tehran University of Medical Sciences在 razi.tums.ac.ir 的电子邮件经过验证
